• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYHS1700711 沙美特罗替卡松吸入气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs(4) Generic Drug 2018-05-30 长风药业股份有限公司 CF PharmTech Inc In Review 2018-05-28 view
JYHB1601402 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2016-11-16 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2017-06-06 view
JYHB2001446 沙美特罗替卡松吸入气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2020-08-21 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production Filed 2020-09-01 view
JYHB1301726 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2014-01-13 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2014-05-22 view
JYHB1401313 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2014-10-14 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2015-05-29 view
JYHZ1900157 沙美特罗替卡松吸入气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs License Renew 2019-07-01 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2019-11-25 view
JYHB1301727 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2014-01-13 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2014-05-22 view
JYHB1400158 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2014-02-13 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2019-03-29 view
JYHB1601401 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2016-11-16 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2017-06-06 view
JYHZ1900158 沙美特罗替卡松吸入气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs License Renew 2019-07-01 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2019-11-25 view
JYHB1401312 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2014-10-14 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production Certificate Issued 2015-05-29 view
JYHB0700936 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2007-09-12 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2008-05-27 view
JYHB1400160 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2014-02-13 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production Certificate Issued 2019-05-24 view
JYHB1600992 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2016-08-11 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production Certificate Issued 2019-05-24 view
JYHB1401314 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2014-10-14 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2015-05-29 view
JYHB1601400 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2016-11-16 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production Certificate Issued 2017-06-06 view
JYHB2100101 沙美特罗替卡松吸入气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2021-01-29 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production In Review 2021-01-28 view
JYHB1400159 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2014-02-13 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Glaxo Smithkline Australia Pty Ltd;Glaxo Wellcome Production Certificate Issued 2019-03-29 view
JYHZ1800391 沙美特罗替卡松吸入气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs License Renew 2018-11-30 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production Certificate Issued 2019-05-24 view
JYHB1100508 沙美特罗替卡松气雾剂 fluticasone propionate;salmeterol xinafoate Aerosol Chemical Drugs Supplementary Application 2011-06-09 葛兰素史克(中国)投资有限公司 GlaxoSmithKline (China) Investment Co Ltd;Laboratoire Glaxosmithkline;Glaxo Wellcome Production Certificate Issued 2012-02-06 view